Offer - Urjas Oil for just ₹ 1 X
Gemiuro Plus is an allopathic medicine The correct dosage of Gemiuro Plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Gemiuro Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gemiuro Plus safe for pregnant women?
Gemiuro Plus can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Gemiuro Plus right away. Take your doctor's advice before taking it again.
Is the use of Gemiuro Plus safe during breastfeeding?
Gemiuro Plus should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Gemiuro Plus on the Kidneys?
Effects of Gemiuro Plus on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of Gemiuro Plus on the Liver?
Gemiuro Plus does not damage the liver.
What is the effect of Gemiuro Plus on the Heart?
There may be an adverse effect on the heart after taking Gemiuro Plus. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Gemiuro Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemiuro Plus unless your doctor advises you to do so -
Is this Gemiuro Plus habit forming or addictive?
Gemiuro Plus does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Gemiuro Plus can make you feel drowsy.
Is it safe?
Gemiuro Plus is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Gemiuro Plus in mental disorders is not effective.
Interaction between Food and Gemiuro Plus
Due to the absence of research, it is difficult to say how Gemiuro Plus and food will interact.
Interaction between Alcohol and Gemiuro Plus
No research has been done on this till date. Therefore, it is not known what the effect of taking Gemiuro Plus with alcohol will be.
Yes, Gemiuro Plus protect the liver. It protects the liver from the damage caused by free radicals because of its antioxidant property.
Yes, Gemiuro Plus may cause nausea. It is a rare side effect of this drug. However, the exact cause of nausea is unknown. If you are experiencing excessive nausea after taking this drug then you are advised to discuss it with your doctor.
No, Gemiuro Plus should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
No, Gemiuro Plus does not treat hepatitis B because it is not an antiviral drug. However, it is used in combination with other drugs in the treatment of hepatitis.
Rarely, Gemiuro Plus might cause diarrhoea. It is a known side effect of this drug. However, the exact cause diarrhoea is unknown. You are advised to drink plenty of water will taking this drug to keep yourself well hydrated.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1344-1345
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 671
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Urso 250® / Urso Forte® (ursodiol)
Highlights of Prescribing Information [Internet]: URSO 250® / URSO Forte® (ursodiol) TABLETS . Initial U.S. Approval: 1997
Gholamreza Karimi,1,* Maryam Vahabzadeh,2 Parisa Lari,2 Marziyeh Rashedinia,2 and Mohammad Moshiri2 [Internet]: “Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases. PMCID: PMC3586829 PMID: 23492971